Stinging Nettle Herb
Urtica dioica herba/folium
Evidence Rating
Confidence Level
Traditions
Last Updated
Summary
Stinging nettle leaf/herb is approved by Commission E and ESCOP for adjuvant treatment of rheumatic and arthritic conditions and as a diuretic for urinary tract inflammation. It acts through NF-kB inhibition, COX-1/2 inhibition, and H1-receptor antagonism. The Mittman (1990) study provided initial evidence for allergic rhinitis, and in vitro work shows multi-target anti-allergic mechanisms. The herb is distinct from nettle root (used for BPH) and should not be confused with it. Safety profile is excellent with minimal side effects.
Drug Interactions
This herb has significant drug interactions. Do not use if you are taking medications without consulting a healthcare provider first. See detailed interaction information below.
Regulatory Status
| Regulatory Body | Status |
|---|---|
| Commission E (Germany) | âś“ Approved |
| ESCOP (European) | âś“ Approved |
| EMA/HMPC (EU) | âś“ Approved |
Metadata
| Field | Detail |
|---|---|
| Common Names (EN) | Stinging nettle (leaf/herb), common nettle, nettle leaf |
| Common Names (DE) | Brennnessel (Blatt/Kraut), Grosse Brennnessel |
| Botanical Name | Urtica dioica L., Urtica urens L. |
| Plant Family | Urticaceae |
| Part Used | Leaves and aerial herb (Urticae folium/herba) — NOT root |
| Evidence Quality Rating | Medium — Commission E and ESCOP monographed; moderate clinical trial evidence for arthritis; limited trial evidence for allergy |
Approved Indications
Commission E (Germany)
- Internally: Supportive treatment of rheumatic complaints
- Internally: Irrigation therapy for inflammatory diseases of the lower urinary tract
- Internally: Irrigation for prevention and treatment of renal gravel (kidney stones)
ESCOP
- Adjuvant in the symptomatic treatment of arthritis, arthroses, and/or rheumatic conditions
- Enhancement of renal elimination of water in inflammatory complaints of the lower urinary tract
EMA/HMPC
- Traditional use: For relief of minor articular pain
- Traditional use: As a diuretic to increase the amount of urine to achieve flushing of the urinary tract as an adjunct in minor urinary complaints
- Classification: Traditional use (not well-established use)
Agreement/Disagreement Analysis
All three bodies agree on rheumatic/articular use and diuretic/urinary tract irrigation. The ESCOP monograph is the most specific about arthritis and arthrosis. None of the official monographs include allergic rhinitis, which remains an off-label/research indication despite promising mechanistic and preliminary clinical data.
Conditions Treated
Approved/Monographed
- Rheumatic complaints (arthritis, arthrosis, rheumatic conditions)
- Inflammatory diseases of the lower urinary tract (irrigation therapy)
- Renal gravel prevention (Commission E)
Researched but Not Formally Approved
- Allergic rhinitis (hay fever) — preliminary clinical and strong in vitro evidence
- Gout (traditional use)
- General anti-inflammatory adjunct
Mechanism of Action
Key Active Compounds
- Caffeic acid esters (caffeoylmalic acid, chlorogenic acid) — anti-inflammatory
- Flavonoids (quercetin, rutin, kaempferol) — antioxidant, anti-allergic
- 13-Hydroxyoctadecatrienoic acid (13-HOTrE) — anti-inflammatory (key compound in Hox alpha extract)
- Organic acids (caffeic acid, ferulic acid)
- Minerals (silicic acid, potassium, calcium, iron)
- Sterols (beta-sitosterol)
Anti-Rheumatic/Anti-Inflammatory Pathways
- NF-kB inhibition: Standardized nettle extracts suppress cytokine production through inhibition of NF-kB activation, achieved by preventing degradation of its inhibitory subunit IkB-alpha
- Matrix metalloproteinase (MMP) suppression: Hox alpha extract and 13-HOTrE significantly suppress IL-1beta-induced expression of MMP-1, MMP-3, and MMP-9 in human chondrocytes in vitro — relevant to cartilage degradation in OA
- COX-1 and COX-2 inhibition: Reduces prostaglandin synthesis
Anti-Allergic Pathways (Rhinitis)
- H1 receptor antagonism: Direct antagonist and negative agonist activity at Histamine-1 receptor
- Mast cell stabilization: Inhibition of mast cell tryptase, preventing degranulation and release of pro-inflammatory mediators
- COX-1 and COX-2 inhibition: Reduces prostaglandin formation
- HPGDS inhibition: Inhibits Hematopoietic Prostaglandin D2 synthase, a central enzyme in allergic inflammation
- Multi-target mechanism distinguishes nettle from single-target antihistamines
Diuretic Mechanism
- Potassium-rich composition contributes to aquaretic (water-eliminating) effect
- Flavonoids may enhance renal blood flow
Clinical Evidence Summary
Arthritis and Rheumatic Conditions
- Commission E and ESCOP approval based on traditional evidence and controlled clinical studies
- Controlled studies demonstrated adjuvant use in arthritis, arthrosis, and rheumatic conditions
- Patient-reported outcomes: 80-95% of patients noted effectiveness; 93-95% reported good tolerability
- Hox alpha extract: Specific standardized extract studied for anti-arthritic activity
- In vitro: suppressed IL-1beta-induced MMP expression in human chondrocytes
- Active compound: 13-HOTrE
Allergic Rhinitis
-
Mittman (1990): Randomized, double-blind study of freeze-dried Urtica dioica in allergic rhinitis
- 98 enrolled, 69 completed
- Freeze-dried nettle rated higher than placebo in global assessments
- Diary data showed only slight superiority over placebo
- 300 mg freeze-dried nettle, taken as needed
- PMID: 2192379 — landmark study but small and methodologically limited
-
Bakhshaee et al. (2017): RCT of Urtica dioica root extract (150 mg Urtidin tablet) vs. placebo for allergic rhinitis
- Note: this used ROOT extract, not leaf — different part
- Showed benefit in symptom scores
-
In vitro evidence (Roschek et al., 2009) is strong:
- Demonstrated multi-target anti-allergic mechanisms
- H1 receptor antagonism, mast cell tryptase inhibition, COX-1/2 inhibition, HPGDS inhibition
- Published in Phytotherapy Research
-
[NEEDS-RESEARCH] Large, well-designed RCTs of nettle leaf specifically for allergic rhinitis are still lacking
Diuretic/Urinary Tract
- Traditional use well-documented
- Limited modern clinical trial data
- Used as part of irrigation therapy protocols in German phytotherapy
European vs. US/Anglophone Consensus
| Dimension | European Position | US/Anglophone Position |
|---|---|---|
| Regulatory status | Commission E and ESCOP approved for rheumatic complaints and urinary irrigation | Dietary supplement; no FDA approval |
| Arthritis use | Established adjuvant therapy in German phytotherapy | Less commonly recommended; some CAM practitioners use it |
| Allergy use | Not in official monographs; used by naturopathic practitioners | Popular in naturopathic medicine; freeze-dried nettle capsules widely available |
| Evidence perception | Moderate acceptance based on traditional evidence + controlled studies | Generally considered under-researched |
| Root vs. leaf distinction | Well-understood in European phytotherapy (leaf = rheuma/allergy; root = BPH) | Often confused in US consumer market |
Safety Profile
Contraindications
- Allergy to Urtica species (rare)
- Edema due to impaired cardiac or renal function: Irrigation therapy contraindicated in these conditions (risk of fluid overload)
Drug Interactions
- Diuretics: Potential additive diuretic effect (theoretical)
- Anticoagulants: Nettle contains vitamin K; large amounts theoretically could reduce warfarin effectiveness (not clinically documented)
- Antihypertensives: Potential additive hypotensive effect
- Lithium: Diuretic effect could reduce lithium excretion, raising levels (theoretical)
- Hypoglycemic agents: Some evidence for blood glucose effects; monitor
Side Effects
- Very well tolerated
- Occasional mild GI discomfort
- Allergic skin reactions (rare, usually from fresh plant contact — stinging hairs contain histamine, formic acid, acetylcholine)
- Dried/processed preparations do not cause stinging
Pregnancy/Lactation
- Insufficient safety data — not recommended during pregnancy (EMA)
- Traditional use as food (young nettle leaves as vegetable) is not considered concerning
- Avoid concentrated extracts during pregnancy as a precaution
Clinical Dosage
Oral Preparations (Commission E / ESCOP)
- Dried herb/leaf for tea (infusion): 8-12 g daily (some sources cite up to 12 g)
- Pressed juice: 10-15 mL of fresh plant juice, 3 times daily
- Dry extract: Various standardized extracts; dosing depends on extract ratio
- Freeze-dried herb (Mittman protocol): 300 mg as needed for allergy symptoms
Hox alpha Extract
- Standardized stinging nettle leaf extract
- Used in rheumatic condition research
- Active compound: 13-HOTrE
- Specific dosing varies by product
Duration
- For rheumatic complaints: can be used long-term as adjuvant therapy
- For urinary irrigation: adequate fluid intake (at least 2 L/day) must accompany use
- For allergic rhinitis: used during allergy season
Key Products (European Market)
- Various nettle leaf tea preparations (Sidroga, etc.)
- Hox alpha (Strathmann) — standardized antirheumatic extract
- Bazoton (nettle leaf extract)
- Urtidin (standardized extract)
Important Distinction: Leaf/Herb vs. Root
| Parameter | Leaf/Herb (this file) | Root (urological module) |
|---|---|---|
| Drug name | Urticae folium/herba | Urticae radix |
| Primary indication | Rheumatic complaints, urinary irrigation, allergic rhinitis | Benign prostatic hyperplasia (BPH) |
| Key compounds | Caffeic acid esters, flavonoids, 13-HOTrE | Lectins (UDA), sterols, lignans |
| Mechanism | Anti-inflammatory (NF-kB, COX, MMP) | 5-alpha-reductase inhibition, SHBG binding |
| Commission E | Approved for rheuma, urinary irrigation | Approved for BPH stages I-II |
Sources
- Commission E Monograph: Urticae herba/folium (Bundesanzeiger)
- ESCOP Monograph: Urticae folium/herba (Nettle leaf/herb)
- EMA/HMPC Assessment Report on Urtica dioica L., Urtica urens L., folium (Final)
- Mittman (1990) “Randomized, double-blind study of freeze-dried Urtica dioica in the treatment of allergic rhinitis” PMID: 2192379
- Roschek et al. (2009) “Nettle extract affects key receptors and enzymes associated with allergic rhinitis” Phytotherapy Research
- Schulze-Tanzil et al. (2002) “Effects of the antirheumatic remedy hox alpha on matrix metalloproteinases in human chondrocytes in vitro” PMID: 11962753
- Altmeyers Encyclopedia: Urticae herba/folium and Urticae folium
- Bakhshaee et al. (2017) “Efficacy of Supportive Therapy of Allergic Rhinitis by Stinging Nettle” PMC5963652
Connections
- Nettle root (urological herbs module): Different part, different indication (BPH), different mechanism
- Butterbur: Alternative herbal approach to allergic rhinitis
- Turmeric Curcumin: Shares NF-kB inhibition mechanism for anti-inflammatory effects
- Licorice: Both have anti-inflammatory properties via different pathways
Related Herbs
Butterbur
Petasites hybridus
Butterbur root extract (Petadolex) has some of the strongest clinical evidence of any herbal product for migraine prevention, with Class 1 RCTs showing 48-68% responder rates at 150 mg/day and a former AAN Level A recommendation. However, butterbur plants naturally contain hepatotoxic pyrrolizidine alkaloids (PAs). Although Petadolex is manufactured to be PA-free, reports of liver injury (whose causal relationship to butterbur is disputed) led to product withdrawal in Germany in 2009 and retirement of the AAN guideline. The herb represents a unique case where strong efficacy evidence collides with unresolved safety questions.
Licorice
Glycyrrhiza glabra
Licorice root is one of the most important herbs in both European and Asian medicine, approved by Commission E and ESCOP for gastric/duodenal ulcers, gastritis, and respiratory catarrh. Its primary active compound glycyrrhizin (and its metabolite glycyrrhetinic acid) has potent anti-inflammatory and mucosal-protective effects but also causes mineralocorticoid-like adverse effects: sodium retention, potassium loss, and hypertension. This limits use to 4-6 weeks and a maximum glycyrrhizin intake of 100 mg/day. DGL (deglycyrrhizinated licorice) was developed to provide GI benefits without the hypertension risk and is effective for peptic ulcer symptoms when taken as chewable tablets.
Turmeric / Curcumin
Curcuma longa
Turmeric is approved in Europe as a traditional medicine for mild digestive complaints. Curcumin, its principal active compound, has potent anti-inflammatory and antioxidant activity in vitro but notoriously poor oral bioavailability. This has spawned a generation of enhanced formulations (Meriva, Longvida, Theracurmin) that dramatically improve absorption. Clinical evidence is most promising for osteoarthritis pain, with emerging data for IBD and metabolic syndrome. A rare but real hepatotoxicity signal has emerged, linked to the HLA-B*35:01 allele.